Skip to main content
. Author manuscript; available in PMC: 2019 Jul 23.
Published in final edited form as: Clin Cancer Res. 2018 Aug 9;24(23):5815–5819. doi: 10.1158/1078-0432.CCR-18-1397

Figure 1.

Figure 1.

A, Coronal CT image of the chest, abdomen, and pelvis 2 weeks prior to T-DM1 treatment is notable for pleural/mediastinal disease with symptomatic pleural effusions. B, After 8 months of T-DM1 therapy, a comparison image shows a complete response in the pleural/mediastinal disease and resolution of the effusions that is maintained for 27+ months.